PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline
• ROA

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Pipeline landscape

PART 07: Market segmentation by molecule type
• Biologics
• Small molecules

PART 08: Geographical segmentation
• Injectable drugs market in Americas
• Injectable drugs market in EMEA
• Injectable drugs market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges
• Market drivers
• Market challenges

PART 11: Market trends
• Rising awareness leading to high demand for injectable drugs
• Increase in industry-academia collaboration
• Expected entry of novel vaccines
• Advent of biosimilars

PART 12: Vendor landscape
• Competitive landscape

PART 13: Key vendor analysis
• AbbVie
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Sanofi
• Other prominent vendors

PART 14: Appendix
• List of abbreviations

List of Exhibits
Exhibit 01: Market scenario: Global injectable drugs market 2016
Exhibit 02: Decisive factors for the choice of ROA
Exhibit 03: Major ROA for drugs intake
Exhibit 04: Types of injections
Exhibit 05: Adverse effects of injectable drugs
Exhibit 06: Global injectable drugs market snapshot
Exhibit 07: Global injectable drugs market 2016-2021 ($ billions)
Exhibit 08: Opportunity analysis in global injectable drugs market
Exhibit 09: Five forces analysis
Exhibit 10: Pipeline molecules by key vendors (Phase III)
Exhibit 11: Key clinical trials of key vendors (Phase III)
Exhibit 12: Global injectable drugs market segmentation by molecule type
Exhibit 13: Global injectable drugs market segmentation by molecule type 2016 and 2021 (%)
Exhibit 14: Global biologics injectable drugs market 2016-2021 ($ billions)
Exhibit 15: Top biologic drugs in the injectable drugs market
Exhibit 16: Global small molecules injectable drugs market 2016-2021 ($ billions)
Exhibit 17: Segmentation of global injectable drugs market based on geography 2016 and 2021 (%)
Exhibit 18: Global injectable drugs market by geography 2016-2021 ($ billions)
Exhibit 19: Market scenario in Americas
Exhibit 20: Injectable drugs market in Americas 2016-2021 ($ billions)
Exhibit 21: Market scenario in EMEA
Exhibit 22: Injectable drugs market in EMEA 2016-2021 ($ billions)
Exhibit 23: Market scenario in APAC
Exhibit 24: Injectable drugs market in APAC 2016-2021 ($ billions)
Exhibit 25: Major indications finding huge applications of injectable drugs
Exhibit 26: Major reasons to use injectable drugs
Exhibit 27: New cases of diabetes by 2040
Exhibit 28: Major complications involved with the injections
Exhibit 29: Major causes of drug shortage
Exhibit 30: Competitive structure analysis of global injectable drugs market
Exhibit 31: AbbVie: Key highlights
Exhibit 32: AbbVie: Strength assessment
Exhibit 33: AbbVie: Strategy assessment
Exhibit 34: AbbVie: Opportunity assessment
Exhibit 35: F. Hoffmann-La Roche: Key highlights
Exhibit 36: F. Hoffmann-La Roche: Strength assessment
Exhibit 37: F. Hoffmann-La Roche: Strategy assessment
Exhibit 38: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 39: GlaxoSmithKline: Key highlights
Exhibit 40: GlaxoSmithKline: Strength assessment
Exhibit 41: GlaxoSmithKline: Strategy assessment
Exhibit 42: GlaxoSmithKline: Opportunity assessment
Exhibit 43: Sanofi: Key highlights
Exhibit 44: Sanofi: Strength assessment
Exhibit 45: Sanofi: Strategy assessment
Exhibit 46: Sanofi: Opportunity assessment

Companies Mentioned
AbbVie, F. Hoffmann-La Roche, GlaxoSmithKline, Sanofi, Bayer, Bristol-Myers Squibb, Merck, Takeda Pharmaceutical, and Teva Pharmaceutical.